Three studies published in The Lancet on Tuesday found that taking aspirin daily could reduce your risk of cancer and stop it from spreading in those who do develop cancer.
Researchers analysed more than 50 studies, and the findings were very consistent across the board. Patients who took aspirin daily were 36 per cent less likely to be diagnosed with metastatic cancer (cancer which has spread to more than one part of the body) and individuals who had taken aspirin for more than five years were 15 per cent less likely to die from cancer.
The results were particularly positive for those suffering from colon cancer. Patients who were diagnosed with localised colon cancer while on the daily aspirin regime halved their chances of the cancer spreading.
Doctors are not yet suggesting that everyone start taking aspirin, but the findings are very positive at this stage, and researchers are now looking into how aspirin could be used to fight cancer more effectively. Remember never to change your medication or start taking a new long-term medication without first discussing it with your doctor.
You can read the three articles at The Lancet website.